We tested the effects of Akt inhibitor VIII, p38 inhibitor SB203580, MEK1, 2 inhibitor U0126, and JNK inhibitor II on AF treatment in AF-sensitive AGS and SNU-216 cells. This evidence concerns the gene AKT1 and atrial fibrillation.